0858.HK Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 10:21):

Extrawell Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, distributes, and sells pharmaceutical products in the People's Republic of China...

Stats
Dzisiejszy wolumen	480 000
Średni wolumen	796 000
Kapitalizacja rynkowa	64.53M
EPS	HKD0 ( 2023-11-29 )
Last Dividend	HKD0 ( N/A )
Next Dividend	HKD0 ( N/A )
P/E	-0.390
ATR14	HKD0 (0.00%)

Extrawell Pharmaceutical Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Extrawell Pharmaceutical Finanse

Annual	2022
Przychody:	HKD72.58M
Zysk brutto:	HKD31.14M (42.91 %)
EPS:	HKD0.0541

FY	2022
Przychody:	HKD72.58M
Zysk brutto:	HKD31.14M (42.91 %)
EPS:	HKD0.0541

FY	2022
Przychody:	HKD73.93M
Zysk brutto:	HKD37.56M (50.80 %)
EPS:	HKD0.0546

FY	2021
Przychody:	HKD78.80M
Zysk brutto:	HKD42.57M (54.02 %)
EPS:	HKD-0.0507

Financial Reports:

No articles found.

Extrawell Pharmaceutical

Extrawell Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, distributes, and sells pharmaceutical products in the People's Republic of China. The company operates through Manufacturing, Trading, and Gene Development segments. It offers transfer factor oral solution, a dual immune regulator for the treatment of diseases caused by virus infection and weak cellular immune system; and Wisk for the treatment of II-III degree of radio-injury of skin, normal common burn, actinic dermatitis, various infectious ulcers, and oral ulcers, as well as for trauma and post operation wound healing. The company also provides ZhouBang, a thromboxane synthetase inhibitor to prevent the coagulation of platelets and facilitate relaxation of blood vessels. In addition, it is involved in the marketing and distribution of imported pharmaceutical products, including Millibar for the treatment of high blood pressure; and development of oral insulin. Further, the company engages in the commercial exploitation and development of genome-related technology; provision of agency services; property investment business; and holding of gene invention rights. Extrawell Pharmaceutical Holdings Limited is headquartered in Quarry Bay, Hong Kong.